Clinical trials for Pancreas cancer

159 currently recruiting clinical trials

Looking for clinical trials?

Clinical trial search is a complex process, with countless criteria to consider. Our AI assistant navigates this complexity with precise, expert-level analysis of the most relevant trials based on your medical profile. Our database is fully up to date, so you see only actively recruiting sites. It's fast and easy:

Create your account
Copy-paste your latest medical report
Our AI-based assistant does the rest for you

Whether you are a patient or a doctor, create an account to find and apply for the most relevant clinical trials:

Create your account

Phase 1 Breast cancer Lung cancer Prostate cancer Colon cancer Rectal cancer Anal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer Bladder / Urinary Tract / Urethral cancer Stomach and esophageal cancer Endometrial cancer Ovarian / Fallopian tubes / Peritoneum cancer #NCT06533059 #2024-515391-12-00

Une étude visant à mieux comprendre le médicament ALTA2618 chez les adultes atteints de tumeurs solides mutées pour le gène AKT1 E17K

Locally Advanced Metastatic AKT 1 2 3 or more

BRAF KRAS G12C KRAS non G12C NRAS HRAS KRAS G12D Systemic Treatment-Naive

4 recruiting sites

Alterome Therapeutics, Inc.

Première étude chez l'humain de l'inhibiteur sélectif de PI3Kα muté, RLY-2608, en monothérapie chez des patients atteints de tumeurs solides avancées et en association avec une hormonothérapie, avec ou sans inhibiteur de CDK4/6 ou de CDK4, chez des patients atteints de tumeurs solides avancées ou d'un cancer du sein avancé.

Cohortes monothérapies (tumeurs solides PIK3CA mutées)

Locally Advanced Metastatic PIK3CA 1 2 3 or more

Systemic Treatment-Naive

3 recruiting sites

Relay Therapeutics, Inc.

Phase 1 Breast cancer Lung cancer Colon cancer Rectal cancer Pancreas cancer Endometrial cancer Ovarian / Fallopian tubes / Peritoneum cancer #NCT06400472 #2024-511238-11-00

Étude du LY4170156 chez des participants atteints de tumeurs solides avancées sélectionnées

NSCLC (Non-Small Cell Lung Cancer) Epithelial ovarian cancer Fallopian tube cancer Primary peritoneal cancer (PPC) HER2 Negative HR Negative 1 2 3 or more

Systemic Treatment-Naive

3 recruiting sites

Eli Lilly et compagnie

Phase 1 Breast cancer Lung cancer Colon cancer Rectal cancer Pancreas cancer #NCT06562192 #2023-510356-23-00

Étude de phase I du [177Lu]Lu-NNS309 chez des patients atteints de cancers du pancréas, du poumon, du sein et colorectal

NSCLC (Non-Small Cell Lung Cancer) Adenocarcinoma HER2 Negative HR Negative HR Positive Locally Advanced Metastatic 1 2 3 or more Immunotherapy Chemotherapy Targeted therapy

Systemic Treatment-Naive

2 recruiting sites

Novartis